Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Small-molecule NFAT signaling inhibitor with dual NFATc1/NFATc2 activity and limited calcineurin catalytic inhibition
Jee Eun Hong; Ye-Seul Song; Su Jung Hwang; Jisong Yoon; Chan Gook Lee; Hye Jung Bang; Seok Ju Park; Jae-Hwan Kwak; Hyo-Jong Lee; Yohan ParkShow moreShow less
1. College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon, Republic of Korea; 2. School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea; 3. College of Pharmacy, Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae, Republic of Korea; 4. Department of Nephrology, College of Medicine, Busan Paik Hospital, Inje University, Busan, Republic of Korea; 5. College of Pharmacy, Chungbuk National University, Cheongju, Republic of KoreaShow moreShow less
DeepSAT-guided discovery of sesquiterpenoid dimers from Inula japonica and identification of a natural pyroptosis inducer targeting the ROS–caspase-3–GSDME pathway
Zhen Gao; Ai-Ying Huang; Hang Yu; Yong-Xue Zhao; An-Cui Wang; Qi-Yuan Mao; Chao-Yang Luo; Bi-Fa Wang; Dong-Bao Hu; Yu-Han Zhao; Xiao Ding; Wei DongShow moreShow less
1. Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China; 2. State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, People’s Republic of China; 3. University of Chinese Academy of Sciences, Beijing, China; 4. School of Chemical Science and Technology, Yunnan University, Kunming, China; 5. School of Chemistry and Environmental Engineering, Yuxi Normal University, Yuxi, People’s Republic of ChinaShow moreShow less
Transcriptomic analysis identifies immune-related clusters and PPP2R1A as a candidate gene associated with venous thromboembolism recurrence
Fengfei Yan; Song Han; Cheng Peng; Bohan Yang; Haiyang WangShow moreShow less
1. Department of Vascular Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaShow moreShow less
Targeting histamine signaling: repurposing antihistamines for cancer chemotherapy and immunotherapy
Manoj Kumar Baniya; Do-Hee Kim; So Jin Sim; Kyung-Soo ChunShow moreShow less
1. College of Pharmacy, Keimyung University, Daegu, Republic of Korea; 2. Department of Chemistry, Kyonggi University, Suwon, Republic of KoreaShow moreShow less
Cannabis in cancer: a review of therapeutic potential, clinical and preclinical status, and legislation
Chhitij Thapa; Hye Jin Kim; Do-Hee Kim; Sangkil Lee; Kyung-Soo ChunShow moreShow less
1. College of Pharmacy, Keimyung University, Daegu, Republic of Korea; 2. Department of Chemistry, Kyonggi University, Suwon, Republic of Korea; 3. College of Pharmacy, Chung-Ang University, Seoul, Republic of KoreaShow moreShow less
Anti-inflammatory phytochemicals from medicinal herbs based on senoinflammation schema for healthy aging
Radha Arulkumar; Sang Gyun Noh; Hee Jin Jung; Seungwoo Kim; Mi Kyung Kim; Eric Lim; Arulkumar Nagappan; Jin Hwan Lim; Hae Young ChungShow moreShow less
1. Interdisciplinary Research Program of Bioinformatics and Longevity Science, Pusan National University, Busan, Republic of Korea; 2. PG & Research Department of Biotechnology & Bioinformatics Holy Cross College (Autonomous) (Affiliated to Bharathidasan University), Tiruchirappalli, India; 3. Research Institute for Drug Development, Pusan National University, Busan, Republic of Korea; 4. Department of Pharmacy, College of Pharmacy, Pusan National University, Busan, Republic of Korea; 5. Division of Nutritional Sciences, Cornell University College of Human Ecology, Ithaca, USA; 6. Department of Pathology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India; 7. Department of Environmental and Occupational Health Program in Public, Health University of California, Irvine, USAShow moreShow less
FAQ
How long does ARCHIVES OF PHARMACAL RESEARCH take to review a manuscript?
As of 2026-11-18, CrushSCI has 15 complete review records for ARCHIVES OF PHARMACAL RESEARCH. The fastest paper went from submission to acceptance in 128 days (Therapeutic potential of glycyrrhizic acid in inflammation-related diseases: from HMGB1-oriented molecular insights to preclinical application, received 2026-02-02, accepted 2026-06-10); the slowest took 375 days. The average is 230.3 days and the median is 219 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
